drugset / Trial / NCT06416709
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for Lung injury caused by major infectious diseases.
Timeline
- Start
- 2023-05-10
- Primary completion
- 2026-05-10
- Completion
- 2026-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 5e+07 cells | Intravenous |